Literature DB >> 2691673

A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome.

D L Goldenberg1.   

Abstract

The rationale behind the use of tricyclic medications in the treatment of fibromyalgia is reviewed. Controlled therapeutic trials have demonstrated significant improvement with these agents. However, important and sustained clinical improvement occurs in the minority of patients.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2691673

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  6 in total

Review 1.  Chronic fatigue syndrome.

Authors:  S Wessely
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

2.  Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia.

Authors:  K J Skeith; M S Hussain; R T Coutts; C Ramos-Remus; J A Avina-Zubieta; A S Russell
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

Review 3.  Fibromyalgia: an age-old malady begging for respect.

Authors:  R Powers
Journal:  J Gen Intern Med       Date:  1993-02       Impact factor: 5.128

4.  Fibromyalgia--the effect of relaxation and hydrogalvanic bath therapy on the subjective pain experience.

Authors:  V Günther; E Mur; U Kinigadner; C Miller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

5.  [Clinical features, pathophysiology and treatment of fibromyalgia.].

Authors:  H C Müller-Busch
Journal:  Schmerz       Date:  1994-09       Impact factor: 1.107

6.  A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  R Klein; P A Berg
Journal:  Clin Investig       Date:  1994-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.